TotalMarketCap

IGC Pharma

IGCNYSE United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$21.591 M

$0.19 -4.67%

Close of 6 Nov 2026

As of 6 Nov 2026, IGC Pharma (IGC) has a market capitalization of $21.6M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$1.27M

#3441 by revenue

Earnings

-$7.12M

Loss-making

Shares outstanding

116,687,169

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #378CervoMedCRVO$22.7M
  2. #379Filana TherapeuticsFLNA$21.7M
  3. #380IGC PharmaIGC$21.6M
  4. #381Seres TherapeuticsMCRB$21.3M
  5. #382ImmutepIMMP$20.6M

What if IGC Pharma were worth as much as…

Open the what-if tool →

Gold $28.2T

$243,123.04

Per share 1,307,816× higher

Bitcoin $1.53T

$13,154.96

Per share 70,764× higher

Apple $5.02T

$43,186.52

Per share 232,310× higher

Or at a round number

$50.0M$100.0M$200.0M$500.0M

Where these numbers come from

Share counts and financials for IGC Pharma are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.